cushing syndrome - Nursing Case Study
Pathophysiology
• Primary mechanism: Cushing syndrome primarily results from prolonged exposure to high cortisol levels, often due to a pituitary adenoma causing excessive adrenocorticotropic hormone (ACTH) secretion, which stimulates adrenal glands to overproduce cortisol.
• Secondary mechanism: Another crucial mechanism is ectopic ACTH production, where non-pituitary tumors secrete ACTH, leading to increased cortisol production and subsequent loss of feedback control.
• Key complication: Persistent hypercortisolism causes complications like hypertension, impaired glucose tolerance, and increased risk of infections due to immunosuppression, significantly impacting patient health and quality of life.
Patient Profile
Demographics:
45-year-old female, office manager
History:
• Key past medical history: Hypertension, prediabetes, obesity
• Current medications: Lisinopril 10 mg daily, Metformin 500 mg twice daily, Hydrochlorothiazide 25 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Progressive weight gain and fatigue
• Key symptoms: Central obesity, facial rounding, muscle weakness, easy bruising, and irregular menstrual cycles
• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 98% on room air
Section 1
New Diagnostic Results:
Following the initial assessment and clinical suspicion of Cushing syndrome, the healthcare team proceeded with a series of diagnostic tests to confirm the diagnosis and evaluate the extent of the condition. The 24-hour urinary free cortisol test revealed markedly elevated levels at 320 mcg/day (normal range: 10-100 mcg/day), confirming hypercortisolism. Additionally, a late-night salivary cortisol test showed persistently high cortisol levels at 0.22 mcg/dL (normal <0.09 mcg/dL), indicating loss of normal diurnal variation. An MRI of the pituitary gland was performed, revealing a 5 mm adenoma suggestive of a pituitary source for the excess ACTH production.
These results solidified the diagnosis of ACTH-dependent Cushing syndrome, likely due to a pituitary adenoma. This finding necessitates a multidisciplinary approach involving endocrinology, neurology, and potentially neurosurgery to discuss management options, including surgical resection of the adenoma. Given the patient's history of hypertension and prediabetes, the team must also consider how these comorbidities may complicate her treatment course and recovery. The elevated cortisol levels contribute to her hypertension and impaired glucose metabolism, requiring ongoing monitoring and potential adjustments to her antihypertensive and diabetic medications. The patient is scheduled for a consultation with an endocrinologist to discuss these findings and formulate a comprehensive treatment plan.
Section 2
Following the confirmation of ACTH-dependent Cushing syndrome and the identification of a pituitary adenoma, the patient was scheduled for a transsphenoidal surgery to resect the adenoma. In preparation for the surgery, the healthcare team closely monitored her vital signs and metabolic parameters. The patient's blood pressure was consistently elevated, averaging 150/95 mmHg, despite being on two antihypertensive medications. Her fasting blood glucose levels were also concerning, consistently hovering around 130 mg/dL, indicating a progression towards diabetes. These findings prompted a review of her medication regimen by the endocrinologist, who recommended the addition of spironolactone to better control her blood pressure and metformin to address her impaired glucose tolerance.
During the preoperative period, the patient began to exhibit new symptoms, including significant weight gain, increased bruising, and muscle weakness. A physical examination revealed facial plethora and supraclavicular fat pads, further confirming the severity of hypercortisolism. Laboratory results showed hypokalemia with serum potassium levels at 3.1 mEq/L (normal range: 3.5-5.0 mEq/L), likely exacerbated by her new medication regimen. The healthcare team adjusted her medications to include potassium supplements and closely monitored her electrolyte levels to prevent further complications.
As the date of the surgery approached, the patient's hypertensive and diabetic management became even more critical. The multidisciplinary team, including the endocrinologist, neurosurgeon, and anesthesiologist, collaborated to optimize her condition for surgery, with the goal of minimizing perioperative risks. The endocrinologist emphasized the need for careful perioperative management of her cortisol levels to prevent adrenal insufficiency post-surgery, planning for a gradual tapering of glucocorticoids. The team's proactive approach in addressing her complications and optimizing her preoperative status laid a solid foundation for her upcoming surgical intervention and subsequent recovery.
Section 3
As the patient approached the date of her transsphenoidal surgery, her condition began to exhibit signs of new complications. During a routine preoperative assessment, the nursing team noted that the patient had developed significant peripheral edema, particularly in her lower extremities. Her weight had increased by an additional 5 kilograms over the past two weeks, despite dietary modifications and medication adjustments. In addition to the edema, the patient reported experiencing more frequent episodes of dizziness and fatigue. These new symptoms prompted the healthcare team to conduct further diagnostic evaluations to identify any underlying causes.
Laboratory tests revealed worsening hypokalemia, with serum potassium levels dropping to 2.8 mEq/L, despite the introduction of potassium supplements. This electrolyte imbalance suggested the potential exacerbation of her mineralocorticoid excess, likely related to her hypercortisolism and the spironolactone therapy. Furthermore, her blood pressure was now fluctuating more widely, with readings as high as 160/100 mmHg, indicating suboptimal control and the need for re-evaluation of her antihypertensive regimen. The patient's fasting blood glucose levels also showed a slight increase, averaging 140 mg/dL, raising concerns about her metabolic stability as she neared her surgical date.
In response to these developments, the interdisciplinary team initiated a more aggressive management plan. The endocrinologist adjusted her spironolactone dosage and considered additional diuretics to address the fluid retention, while also increasing her potassium supplementation. The team also explored alternative antihypertensive strategies to achieve better blood pressure control. Concurrently, the patient was educated about the importance of adherence to her medication regimen and dietary recommendations to optimize her preoperative condition. As the team worked diligently to stabilize her clinical status, they remained vigilant for any further complications or changes in her health, ensuring she was as prepared as possible for her upcoming surgery.
Section 4
As the patient continued with the adjusted management plan, the healthcare team closely monitored her response to the interventions. Over the following week, there was a notable improvement in the peripheral edema; however, the episodes of dizziness persisted. During a follow-up assessment, the nursing team observed that the patient appeared more lethargic than before, and her gait was unsteady. Vital signs revealed a blood pressure of 150/95 mmHg, indicating some improvement but still requiring optimization. Her heart rate remained elevated at 105 beats per minute. Despite increased potassium supplementation, her serum potassium level remained low at 3.0 mEq/L.
New diagnostic evaluations were conducted to further investigate the persistent dizziness and lethargy. An ECG was performed, revealing the presence of U waves, which are suggestive of ongoing hypokalemia. Additionally, a repeat blood glucose test showed a further increase in fasting levels to 160 mg/dL, prompting the team to consider the possibility of incipient glucose intolerance or worsening insulin resistance. An MRI was also ordered to rule out any central causes for her neurological symptoms, given her history of Cushing's syndrome and the upcoming transsphenoidal surgery.
The team convened to reassess the patient's management plan in light of these findings. They decided to initiate a low-dose insulin regimen to better control her glucose levels and prevent further metabolic complications. The endocrinologist also recommended the addition of a beta-blocker to help manage her heart rate and blood pressure fluctuations. The nursing team emphasized the importance of monitoring for signs of further electrolyte imbalances and potential adverse effects of the new medications. As they prepared for the next phase of the patient's care, the team remained focused on stabilizing her condition to ensure she was in the best possible state for her scheduled surgery.
Section 5
As the patient's care plan progressed, the healthcare team closely monitored her response to the newly introduced interventions. Initially, there was a positive response to the insulin regimen, with blood glucose levels stabilizing around 130 mg/dL, suggesting improved glycemic control. However, the patient began to experience episodes of palpitations and increased fatigue, prompting further evaluation. Her blood pressure readings fluctuated significantly, ranging from 140/90 mmHg in the morning to peaks of 160/100 mmHg in the evening, despite the beta-blocker therapy. The heart rate remained consistently elevated at 110 beats per minute, raising concerns about the adequacy of the current cardiovascular management approach.
During a subsequent nursing assessment, the patient reported a new onset of muscle weakness, particularly in her lower limbs, and an increase in the frequency of dizziness. A comprehensive electrolyte panel indicated that despite aggressive potassium supplementation, her serum potassium had further decreased to 2.8 mEq/L, confirming worsening hypokalemia. This prompted a review of her medication regimen and dietary intake to identify potential sources of potassium loss. Additionally, the persistence of U waves on a follow-up ECG reinforced the urgent need to address this imbalance to prevent further cardiac complications.
In light of these developments, the healthcare team decided to intensify the potassium replacement therapy and reconsider the type and dosage of the antihypertensive medications, aiming to stabilize her cardiovascular status more effectively. They also planned to collaborate with a dietitian to optimize her nutritional intake to support electrolyte balance. The nursing team remained vigilant for any signs of further muscular or neurological deterioration, preparing to adjust the care plan as needed. As the patient's condition evolved, the team was acutely aware of the need to manage these moderate complications to ensure her readiness for the upcoming transsphenoidal surgery.